{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T16:37:46Z","timestamp":1700066266040},"reference-count":29,"publisher":"Frontline Medical Communications, Inc.","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.sder.2006.05.002","type":"journal-article","created":{"date-parts":[[2006,8,13]],"date-time":"2006-08-13T07:06:09Z","timestamp":1155452769000},"page":"87-90","source":"Crossref","is-referenced-by-count":4,"title":["What\u2019s New in Cutaneous T-Cell Lymphomas: 2006"],"prefix":"10.12788","volume":"25","author":[{"given":"Joan","family":"Guitart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2006.05.002_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","article-title":"WHO\/EORTC classification of cutaneous lymphomas 2005","volume":"32","author":"Burg","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.sder.2006.05.002_bib2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.sder.2006.05.002_bib3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"International Society for Cutaneous Lymphoma. Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archderm.141.3.361","article-title":"Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythroderma","volume":"141","author":"Gniadecki","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/00015550510030087","article-title":"A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides","volume":"85","author":"Vakeva","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2006.05.002_bib6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archderm.140.9.1156","article-title":"Neoplastic stem cells in cutaneous lymphomas","volume":"140","author":"Gniadecki","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archderm.141.5.641","article-title":"Do neoplastic stem cells underlie the pathogenesis of cutaneous lymphomas?","volume":"141","author":"Vonderheid","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2004.06325.x","article-title":"Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7","volume":"152","author":"Sokolowska-Wojdylo","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib9","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.sder.2006.05.002_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.jid.5700029","article-title":"Increased expression of ctla-4 in malignant T-cells from patients with mycosis fungoides\u2014cutaneous T cell lymphoma","volume":"126","author":"Wong","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaad.2005.07.044","article-title":"CD8(+) T lymphocytes reactive against Epstein-Barr virus antigens in skin lesions of a patient with Sezary syndrome","volume":"53","author":"Knol","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib12","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archderm.141.10.1235","article-title":"Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases","volume":"141","author":"Trento","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2133.2005.06524.x","article-title":"On the possible relationship between staphylococcal superantigens and increased Vbeta5.1 usage in cutaneous T-cell lymphoma","volume":"152","author":"Vonderheid","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.0022-202X.2004.23586.x","article-title":"Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma","volume":"124","author":"Vonderheid","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaad.2005.06.001","article-title":"Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sezary syndrome","volume":"53","author":"Introcaso","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2133.2005.06755.x","article-title":"Circulating CD8+ lymphocytes, white blood cells, and survival in patients with mycosis fungoides","volume":"153","author":"Abeni","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000080852","article-title":"Serological immunomarkers in cutaneous T cell lymphoma","volume":"209","author":"Hassel","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.sder.2006.05.002_bib18","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/j.1365-2133.2005.06621.x","article-title":"Is bone marrow biopsy necessary in patients with mycosis fungoides and Sezary syndrome? A histological and molecular study at diagnosis and during follow-up","volume":"152","author":"Beylot-Barry","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jaad.2004.12.018","article-title":"Papular mycosis fungoides","volume":"52","author":"Kodama","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1365-2133.2005.06877.x","article-title":"Pathogenetic mechanisms of vitiligo in a patient with Sezary syndrome","volume":"153","author":"Knol","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib21","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1365-2133.2005.06620.x","article-title":"Complicated mycosis fungoides mimicking facial erysipelas","volume":"152","author":"Brill","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib22","first-page":"53","article-title":"Oral involvement in lymphomatoid papulosis","volume":"210","author":"Pujol","year":"2005","journal-title":"Report of two cases and review of the literature Dermatology"},{"key":"10.1016\/j.sder.2006.05.002_bib23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archderm.141.9.1117","article-title":"Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids","volume":"141","author":"deq Uatrebarbes","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaad.2004.04.049","article-title":"Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream","volume":"52","author":"Deeths","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1468-3083.2005.01317.x","article-title":"Efficacy of narrowband UVB phototherapy in early stage of mycosis fungoides","volume":"20","author":"Kural","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2006.05.002_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaad.2005.03.012","article-title":"Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides","volume":"53","author":"Boztepe","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2230.2005.01840.x","article-title":"Narrow-band UVB in the treatment of early stage mycosis fungoides","volume":"30","author":"Ghodsi","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2006.05.002_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0609.2005.00497.x","article-title":"Marche Regional Multicentric Study Group of Cutaneous Lymphomas. Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides","volume":"75","author":"Rupoli","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.sder.2006.05.002_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archderm.141.3.305","article-title":"Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy","volume":"141","author":"Querfeld","year":"2005","journal-title":"Arch Dermatol"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562906000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562906000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T04:29:34Z","timestamp":1497673774000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/abstract\/what-is-new-in-cutaneous-t-cell-lymphomas-2006\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1085562906000368"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2006.05.002","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}